GRB7-mediated enhancement of cell malignant characteristics induced by Helicobacter pylori infection

Huilin Zhao, Si Chen, Xinfeng Bai, Jianhui Zhang, Shuzhen Liu, Zekun Sun, Xinying Cao, Jianping Wang, Ying Zhang, Boqing Li, Xiaofei JiFrontiers in Microbiology 2024 · DOI

This study, published in Frontiers in Microbiology, explores the molecular mechanisms by which Helicobacter pylori (H. pylori) infection drives the progression of gastric cancer. The researchers identify a specific signaling axis—CagA-STAT3-GRB7-ERK—that the bacteria hijack to turn healthy gastric cells into malignant ones.

TL;DR

H. pylori infection promotes gastric cancer by triggering the overexpression of the protein GRB7 via the STAT3 signaling pathway. This increase in GRB7 activates ERK signaling, which accelerates cell growth, aids migration, and prevents programmed cell death, identifying GRB7 as a potential therapeutic target for preventing gastric carcinogenesis.

What Problem Does This Paper Address?

Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide. While H. pylori infection is the primary risk factor, the precise molecular "wiring" that links the infection to the development of malignant cell traits is still being mapped.

The protein GRB7 (Growth factor receptor-bound protein 7) is known to be overexpressed in many cancers and is linked to poor prognosis. However, its specific role in H. pylori-induced gastric cancer was poorly understood. This paper seeks to determine if H. pylori directly influences GRB7 and how that protein, in turn, changes cell behavior to favor cancer.

Methods

The researchers employed a multi-level approach combining clinical data, cell cultures, and animal models:

  • Clinical Analysis: They used the GEPIA database and immunohistochemical (IHC) staining of human gastric cancer tissues to correlate GRB7 levels with patient survival and infection status.
  • In Vitro (Cell) Studies: Gastric cancer cell lines (AGS and MGC-803) were infected with H. pylori. They used siRNA to "knock down" (silence) specific genes and plasmids to "overexpress" them, allowing them to map the signaling pathway.
  • Functional Assays: To measure malignancy, they performed EdU staining (proliferation), Transwell and wound-healing assays (migration/invasion), and flow cytometry (cell cycle and apoptosis).
  • In Vivo (Animal) Studies: C57BL/6 mice were orally inoculated with H. pylori (strain SS1) for four weeks to observe changes in the gastric mucosa and protein expression in a living system.

Datasets

  • GEPIA Database: Used for initial gene expression profiling and survival analysis in gastric adenocarcinoma.
  • Clinical Samples: 10 pairs of gastric cancer and paracancerous tissues, plus 27 gastritis tissue samples (12 H. pylori-positive and 15 -negative) provided by Yantai Affiliated Hospital.

Key Insights and Ideas

  • The STAT3 Connection: The study identifies the transcription factor STAT3 as the critical "middleman." H. pylori activates STAT3, which then travels to the nucleus to drive the production of GRB7.
  • CagA as the Trigger: The bacteria's primary virulence factor, CagA, is essential for this process. When cells were infected with a CagA-deficient strain of H. pylori, the upregulation of GRB7 was significantly diminished.
  • GRB7 as a Signal Hub: GRB7 acts as an adapter protein that funnels signals into the ERK pathway. This pathway is a notorious driver of cancer, pushing cells to divide faster and resist the body’s natural "self-destruct" signals (apoptosis).
  • EMT Induction: GRB7 was found to promote the Epithelial-Mesenchymal Transition (EMT), a process where stationary epithelial cells gain the ability to migrate and invade other tissues—the hallmark of metastasis.

Key Results

  • Expression: GRB7 is significantly higher in GC tissues than in normal tissues, and patients with high GRB7 have lower overall survival rates.
  • Infection Response: Just 4 hours of H. pylori treatment significantly increased GRB7 mRNA and protein levels in gastric cells.
  • Pathway Validation: Inhibiting STAT3 (either via siRNA or the chemical inhibitor Stattic) blocked the H. pylori-induced rise in GRB7.
  • Cellular Impact: Overexpressing GRB7 increased the proportion of cells in the S-phase (DNA synthesis) and decreased the rate of apoptosis. Conversely, knocking down GRB7 reversed the malignant effects of H. pylori infection.
  • Animal Model: Infected mice showed elevated GRB7, p-STAT3, and p-ERK in their gastric mucosa, alongside visible inflammatory and precancerous changes.

Limitations and Future Work

  • Strain Diversity: H. pylori is genetically diverse. This study used specific laboratory strains (26695 and SS1), so the results may not represent all clinical infections.
  • Direct Interaction: While the study maps the pathway, it doesn't fully explore if CagA interacts directly with the GRB7 protein (as some previous high-throughput studies have suggested) or if the interaction is purely through the STAT3 transcriptional route.
  • Therapeutic Translation: While GRB7 is identified as a target, the study does not test specific GRB7-inhibiting drugs in the mouse model to see if they can halt the progression of H. pylori-associated gastric disorders.

Summary updated

Abstract

Growth factor receptor bound protein 7 (GRB7) is reportedly upregulated in human gastric cancer (GC), which is closely associated with tumor progression and prognosis. However, the mechanism underlying its dysregulation in GC remains poorly understood. In this study, we found that GRB7 overexpression was associated with <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection. GC cells (AGS and MGC-803) infection assays revealed that this upregulation was mediated by the transcription factor STAT3, and activation of STAT3 by <i>H. pylori</i> promoted GRB7 expression in infected GC cells. Moreover, CagA, the key virulence factor of <i>H. pylori</i>, was found involved in STAT3-mediated GRB7 overexpression. The overexpressed GRB7 further promoted GC cell proliferation, migration, and invasion by activating ERK signaling. Mice infection was further used to investigate the action of GRB7. In <i>H. pylori</i> infection, GRB7 expression in mice gastric mucosa was elevated, and higher STAT3 and ERK activation were also detected. These results revealed GRB7-mediated pathogenesis in <i>H. pylori</i> infection, in which <i>H. pylori</i> activates STAT3, leading to increased GRB7 expression, then promotes activation of the ERK signal, and finally enhances malignant properties of infected cells. Our findings elucidate the role of GRB7 in <i>H. pylori</i>-induced gastric disorders, offering new prospects for the treatment and prevention of <i>H. pylori</i>-associated gastric carcinogenesis by targeting GRB7.
BibTeX
@inproceedings{zhao2024grb,
  author = {Huilin Zhao and Si Chen and Xinfeng Bai and Jianhui Zhang and Shuzhen Liu and Zekun Sun and Xinying Cao and Jianping Wang and Ying Zhang and Boqing Li and Xiaofei Ji},
  title = {{GRB7-mediated enhancement of cell malignant characteristics induced by Helicobacter pylori infection}},
  booktitle = {Frontiers in Microbiology},
  year = {2024},
  doi = {10.3389/fmicb.2024.1469953},
}
Figure